Biocon

Company Overview

Biocon is a biopharmaceutical company headquartered in Bangalore, India. Established in 1978, it is a leading global biotechnology and pharmaceutical industry player. Biocon Ltd. specializes in developing and manufacturing innovative and affordable biopharmaceuticals for various therapeutic areas, including diabetes, oncology, immunology and cardiology. The company is known for its expertise in biosimilars and has a significant presence in insulin and monoclonal antibodies. Biocon Ltd. has garnered international recognition for its contributions to the biotech sector and has formed strategic collaborations with global pharmaceutical companies. With a commitment to research and development, Biocon Ltd. continues to make strides in bringing accessible and high-quality healthcare solutions to patients worldwide.

Financial Highlights (FY 2023)

Company's Business Segments

• Generics : This segment portfolio comprises more than 60 products across cardiology, oncology, immunology, and autoimmune indications.
• Biosimilars : This segment specializes in developing, manufacturing, and commercializing a differentiated and comprehensive biosimilars portfolio including insulins, monoclonal antibodies and conjugated recombinant proteins.
• Research Services : This segment revenue is generated from Syngene, a wholly owned subsidiary of the company.